CT angiography can help clinicians detect cerebral aneurysms smaller than 3 mm.
CT angiography accurately detects small cerebral aneurysms smaller than 3 mm, according to a study published in Radiology.
Researchers from China performed a retrospective study to assess the accuracy of CT angiography for the diagnosis of cerebral aneurysms that were 5 mm or smaller, using digital subtraction angiography (DSA) as a reference standard.
The study group included 1,366 patients who underwent both CT angiography and DSA. Two readers assessed CT performance for depiction of aneurysms, size, location, and status of rupture.
The results showed DSA detected 711 small aneurysms in 579 patients. Using DSA as the reference standard the researchers found:
The researchers noted that the sensitivities of CT angiography were lower for detection of aneurysms smaller than 3 mm and unruptured compared with aneurysms that were 3 to 5 mm and ruptured. There were no differences for the sensitivities of CT angiography for diagnosis of aneurysms in the anterior versus posterior circulation. Excellent or good interreader agreement was found for detection of intracranial aneurysms on a per-patient and per-aneurysm basis.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.